Subscribe
Home Economics Jim Grant: Biotech Most Worrisome Portion Of Stock Market

Jim Grant: Biotech Most Worrisome Portion Of Stock Market

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

“The Fed has its thumb on the scales of our finances,” says Jim Grant of Grant’s Interest Rate Observer, weighing in on Janet Yellen and the Fed’s interest rate policy.

H/T Value investing

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Sheeraz Raza
Editor

Related news

Powell: Inflation Could Be “More Volatile”
Dave Kovaleski
Retail Sales Rise in April, But Growth Slows from March
Dave Kovaleski
Consumer Price Index CPI
CPI Inflation Drops to 2.3% in April, Hits 4-year Low
Dave Kovaleski
top ten general merchandisers
CPI Inflation, Retail Sales Highlight Week Ahead, Walmart Earnings in Focus
Dave Kovaleski
Stocks Skyrocket at Open on U.S.-China Tariff Pause
Dave Kovaleski

Must Read

New

How to Invest in Stocks in 2025 – Beginner’s Guide

Investing in stocks can be a great way to improve your overall wealth – but...

23 Min Read Read now

Latest News

Capital One
Banking

Done Deal: Capital One Closes on Acquisition of Discover
Dave Kovaleski54 minutes

Markets are still digesting what this mega merger means for Capital One stock. Capital One Financial (NYSE: COF) officially closed Sunday on its $35 billion acquisition of Discover Financial Services....

Categories

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.